Journey Medical Corp (DERM) financials
Journey Medical revenue and earnings by year
Journey Medical's revenue was $61.9 million in the fiscal year to December 31, 2025, up 10.2% from the year before. Net income was -$11.4 million, -18.5% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 10.0% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 7 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 62 | 56 | 79 | 74 | 63 | 45 | 35 |
| Revenue growth | 10.2% | -29.1% | 7.5% | 16.7% | 41.8% | 27.5% | — |
| Gross profit | 41 | 35 | 56 | 43 | 31 | 30 | 24 |
| Gross margin | 66.2% | 62.8% | 71.1% | 58.2% | 49.2% | 67.2% | 69.8% |
| Operating income | -8 | -14 | -2 | -28 | -35 | 8 | 5 |
| Operating margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | 17.6% | 15.1% |
| Net income | -11 | -15 | -4 | -30 | -44 | 5 | 4 |
| Net margin | -18.5% | -26.1% | -4.9% | -40.2% | -69.7% | 11.9% | 10.4% |
| Diluted EPS | -$0.47 | -$0.72 | -$0.21 | -$1.69 | -$4.32 | — | — |
| Free cash flow | -12 | -9 | 5 | -14 | -2 | 5 | 9 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open DERM in Markets.
How Journey Medical makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Emrosi | $8.07M | 45.3% |
| Qbrexza | $5.11M | 28.7% |
| Accutane | $3.36M | 18.8% |
| Foam Franchise Products Amzeeq Zilxi | $941K | 5.3% |
| Other Legacy | $232K | 1.3% |
| Eurax | $120K | 0.7% |
See also: DERM returns
No forecast, no recommendation. This page describes Journey Medical Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.